These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6882000

  • 1. [Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)].
    Majima H.
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):805-10. PubMed ID: 6882000
    [Abstract] [Full Text] [Related]

  • 2. [Phase II study of 4'-O-tetrahydropyranyl-adriamycin (THP-ADM) in patients with gynecological cancer].
    Kato T, Nishimura H, Umezu J, Takeuchi S, Kanazawa K, Inoue H, Suzuki M, Hirono M, Suzuki T, Okajima H.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1962-7. PubMed ID: 4051511
    [Abstract] [Full Text] [Related]

  • 3. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].
    Nakada H, Ogawa M, Miyamoto H, Inagaki J, Horikoshi N, Inoue K, Ikeda K, Usui N, Adachi K, Okada Y.
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):138-42. PubMed ID: 6696455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].
    Wakui A, Yokoyama M, Konno K, Nakai Y, Sakano T, Koyama Y, Imamura Y, Nakajima O, Niijima T, Akaza H.
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):118-24. PubMed ID: 3966806
    [Abstract] [Full Text] [Related]

  • 6. Clinical studies of (2''R)-4'-O-tetrahydropyranyl adriamycin (THP).
    Majima H, Ohta K.
    Biomed Pharmacother; 1987 Jan; 41(5):237-43. PubMed ID: 3311190
    [Abstract] [Full Text] [Related]

  • 7. [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].
    Kimura K.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):368-75. PubMed ID: 3947112
    [Abstract] [Full Text] [Related]

  • 8. An oriented phase II trial of THP-adriamycin in breast carcinoma.
    Mathé G, Umezawa H, Oka S, Misset JL, Brienza S, de Vassal F, Musset M, Ribaud P, Tapiero H.
    Biomed Pharmacother; 1986 Feb; 40(10):376-9. PubMed ID: 3580506
    [Abstract] [Full Text] [Related]

  • 9. [THP-adriamycin in head and neck tumor].
    Honda T, Ohyama W, Sonoda T, Uchida K, Hirokawa T, Takada K, Takeda C.
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2538-44. PubMed ID: 6651307
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H, Iguchi H, Tone H.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):542-8. PubMed ID: 3954376
    [Abstract] [Full Text] [Related]

  • 11. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S, Tucci A, Villani G, Carteni G, Spadini N, Palumbo R.
    Anticancer Res; 2000 Mar; 20(1B):485-91. PubMed ID: 10769710
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y, Kubota T, Kuo TH, Furukawa T, Kase S, Tanino H, Ishibiki K, Kitajima M, Hoffman RM.
    Anticancer Res; 1994 Mar; 14(2A):469-73. PubMed ID: 8017850
    [Abstract] [Full Text] [Related]

  • 13. [Phase II study of (2''R)-4'-O-tetrahydropyranyldoxorubicin (THP) in patients with advanced gastrointestinal cancer--a report of the Tohoku THP Study Group].
    Wakui A, Yokoyama M, Yoshida Y, Kikuchi Y, Osawa I, Masamune O, Matsuoka T, Sato S, Kikuchi K, Shoji T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1032-7. PubMed ID: 3963848
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacokinetic studies on THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):865-70. PubMed ID: 3566297
    [Abstract] [Full Text] [Related]

  • 15. [A study on the correlation between the concentration of antitumor agent and the clinical effect. An experience with THP-ADM].
    Ogawa A, Yamashita K.
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):303-8. PubMed ID: 3970553
    [Abstract] [Full Text] [Related]

  • 16. Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC).
    Chauvergne J, Fumoleau P, Cappelaere P, Metz R, Armand JP, Chevallier B, Kerbrat P, de Forni M, Lhommé C, Roche H.
    Eur J Cancer; 1993 Feb; 29A(3):350-4. PubMed ID: 8398333
    [Abstract] [Full Text] [Related]

  • 17. [A phase I trial of 4'-epiadriamycin].
    Ogawa M, Ikeda K, Inagaki J, Horikoshi N, Inoue K, Nakada K, Usui N, Okada Y, Adachi K, Tada A.
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
    [Abstract] [Full Text] [Related]

  • 18. [A phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with head and neck cancer].
    Takeda C.
    Gan To Kagaku Ryoho; 1986 May; 13(5):1970-9. PubMed ID: 3707155
    [Abstract] [Full Text] [Related]

  • 19. [Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy].
    Takagi T, Oguro M, Iwabuchi K.
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1450-6. PubMed ID: 6588924
    [Abstract] [Full Text] [Related]

  • 20. [Phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in gastrointestinal cancer].
    Takenaka K, Tamada R, Hiramoto Y, Inokuchi K, Saku M, Oka N, Kano T, Noda S, Nagasaki S, Toda T.
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2155-60. PubMed ID: 4062315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.